Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.42 USD | +1.14% | -0.93% | -5.65% |
17/04 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
17/04 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
Sales 2024 * | 3.39M 283M | Sales 2025 * | 3.13M 261M | Capitalization | 2.47B 206B |
---|---|---|---|---|---|
Net income 2024 * | -170M -14.19B | Net income 2025 * | -203M -16.95B | EV / Sales 2024 * | 644 x |
Net cash position 2024 * | 285M 23.82B | Net cash position 2025 * | 372M 31.1B | EV / Sales 2025 * | 669 x |
P/E ratio 2024 * |
-12.9
x | P/E ratio 2025 * |
-11.5
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | +1.14% | ||
1 week | -0.93% | ||
1 month | -10.84% | ||
3 months | +6.25% | ||
6 months | +59.10% | ||
Current year | -5.65% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 01/83/01 |
Anthony Marucci
FOU | Founder | 62 | 01/83/01 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 01/08/01 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 16/22/16 |
Harry H. Penner
BRD | Director/Board Member | 78 | 01/97/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +4.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 37.42 | +1.14% | 526,446 |
29/24/29 | 37 | +1.93% | 499,042 |
26/24/26 | 36.3 | +0.11% | 324,978 |
25/24/25 | 36.26 | -2.05% | 1,021,746 |
24/24/24 | 37.02 | -1.99% | 394,653 |
Delayed Quote Nasdaq, April 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 2.47B | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- CLDX Stock